Truth in clinical research trials involving pharmaceutical sponsorship

---

• 1.
• Health and Medical Research Strategic Review. The virtuous cycle. Working together for health and medical research. Canberra: Canberra Info 1999.
• 2.
• Chalmers I. Underreporting research is scientific misconduct. JAMA 1990; 263: 1405-1408.
• 3.
• Bodenheimer T. Uneasy alliance — clinical investigators and the pharmaceutical industry. New Engl J Med 2000; 342: 1539-1544.
• 4.
• Angell M. The pharmaceutical industry — to whom is it accountable? New Engl J Med 2000; 342: 1902-1904.
• 5.
• Rennie D. Fair conduct and fair reporting of clinical trials. JAMA 1999; 282: 1766-1768.
• 6.
• Hailey D. Scientific harassment by pharmaceutical companies: time to stop. CMAJ 2000; 162: 212-213.
• 7.
• Weatherall D. Academia and industry: increasingly uneasy bedfellows. Lancet 2000; 355: 1574.
• 8.
• Larkin M. Whose article is it anyway? Lancet 1999; 354: 136.
• 9.
• Rogers v Whitaker (1992) 175 CLR 479.
• 10.
• Chalmers I. What do I want from health research and researchers when I am a patient? BMJ 1995; 310: 1315-1318.
• 11.
• Royal Australasian College of Physicians. Ethical guidelines in the relationship between physicians and the pharmaceutical industry. Sydney: The College, 2000.
• 12.
• National statement on ethical conduct in research involving humans. Canberra: National Health and Medical Research Council, 1999.
• 13.
• Pyle G. The drug-body snatchers; No cure, Mrs James, but thanks for all the money; Playing patients in the fast lane; It's the money they have to have. Sydney Morning Herald 13 Feb 2001: 1,4.
• 14.
• Pyle G. Patient drug tests enrich hospitals; Vulnerable used as guinea pigs but who guards the guardians? Sydney Morning Herald 14 Feb 2001: 1,4.
• 15.
• Savulescu J, Chalmers I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ 1996; 313: 1390-1393.
• 16.
• Wise P, Drury M. Pharmaceutical trials in general practice: the first 100 protocols. An audit by the clinical research ethics committees of the Royal College of General Practice. BMJ 1996; 313: 1245-1248.
• 17.
• Scroccaro G, Venturini F, Alberti C, et al. Registering clinical trials. BMJ 2000; 320: 1339.
• 18.
• Roughead E, Gilbert A, Primrose J, Sansom LN. Drug related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-408.
• 19.
• Angell M. Is academic medicine for sale? New Engl J Med 2000; 342: 1515-1518.
• 20.
• Lemmens T, Singer PA. Bioethics for clinicians: 17. Conflict of interest in research, education and patient care. CMAJ 1998; 159: 960-965.
• 21.
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000; 283: 2701-2711.
• 22.
• Boyd EA, Bero LA. Assessing faculty financial relationships with industry. A case study. JAMA 2000: 284: 2209-2214.
• 23.
• DeAngelis C. Conflict of interest and the public trust. JAMA 2000; 284: 2237-2238.